New Delhi, September 29: The Drugs controller general of India (DCGI) allowed the export of approximately 2 lakh vaccine doses of Malaria which is pro...
New Delhi, September 1: The Serum Institute of India (SII) and the Department of Biotechnology (DBT) are set to launch India's first self developed Qu...
New Delhi, August 31: The Serum Institute of India (SII) and the Department of Biotechnology(DBT) will launch India's first indigenously developed Qua...
New Delhi, May 3: Serum Institute of India (SII) CEO Adar Poonawalla on Tuesday announced that the Covid-19 vaccine Covovax is now available for child...
New Delhi: The Union government clarified in the Supreme Court on Tuesday that it has not made Covid-19 vaccines mandatory and has only stated that va...
New Delhi, March 9: The Drugs Controller General of India (DCGI) has granted Emergency Use Authorisation (EUA) to Serum Institute of India's (SII) C...
Geneva (Switzerland): The World Health Organisation (WHO) has approved Covid-19 vaccine Covovax, which is manufactured by the Serum Institute of Ind...
The Serum Institute of India (SII) has sought India's drug regulator's approval for the Covishield vaccine as a booster dose citing adequate stock of ...
In a major development, the Pune-based Serum Institute of India (SII) will be manufacturing the COVID-19 vaccine Sputnik V in the month of September.
...
The Serum Institute of India (SII) is planning to start clinical trials of the Novavax vaccine against Covid-19 for children in July, ANI reported on ...
